Aalysis of clinical efficacy of erythromycin and azithromycin sequential therapy in the treatment of children with mycoplasma pneumonia
Sun Enpin
Abstract
Sun Enpin
Abstract
Objective To study the effect of erythromycin and azithromycin sequential therapy in the treatment of children with mycoplasma pneumonia.Methods Erythromycin and azithromycin sequential therapy and the tradition erythromycin and azithromycin combined treatment of 224 cases of children with mycoplasma pneumonia were performed,and the patients' data were analyzed retrospectively.Results The patients in the treatment group was significantly better than the control group,the total efficiency was 96.82%,with short treatment cycle.Conclusion Erythromycin combined with azithromycin sequential therapy is effective to improve the treatment effect of patients,and reduce the adverse situation of patients during treatment.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the effect of erythromycin and azithromycin sequential therapy in the treatment of children with mycoplasma pneumonia.Methods Erythromycin and azithromycin sequential therapy and the tradition erythromycin and azithromycin combined treatment of 224 cases of children with mycoplasma pneumonia were performed,and the patients' data were analyzed retrospectively.Results The patients in the treatment group was significantly better than the control group,the total efficiency was 96.82%,with short treatment cycle.Conclusion Erythromycin combined with azithromycin sequential therapy is effective to improve the treatment effect of patients,and reduce the adverse situation of patients during treatment.
Key concepts: Azithromycin, Medicine, Erythromycin, Mycoplasma pneumonia, Pneumonia, Internal medicine, Adverse effect, Mycoplasma